CENEGERMIN (Oxervate®)
Clinical Indication
Neurotrophic keratitis
Comments
Not recommended in NICE TA 532
Date of classification
August 2018
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.